Literature DB >> 20478744

Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.

Tatiana Akimova1, Guanghui Ge, Tatiana Golovina, Tatiana Mikheeva, Liqing Wang, James L Riley, Wayne W Hancock.   

Abstract

Histone/protein deacetylases (HDACs) decrease histone and protein acetylation, typically leading to suppression of gene transcription and modulation of various protein functions. We found significant differences in expression of HDAC before and after stimulation of human T regulatory (Treg) and T effector cells, suggesting the potential for future selective targeting of Tregs with HDAC inhibitors (HDACi). Use of various HDACi small molecules enhanced, by up to 4.5-fold (average 2-fold), the suppressive functions of both freshly isolated and expanded human Tregs, consistent with our previous murine data. HDACi use increased Treg expression of CTLA-4, a key negative regulator of immune response, and we found a direct and significant correlation between CTLA-4 expression and Treg suppression. Hence, HDACi compounds are promising pharmacologic tools to increase Treg suppressive functions, and this action may potentially be of use in patients with autoimmunity or post-transplantation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478744      PMCID: PMC2917523          DOI: 10.1016/j.clim.2010.04.018

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  55 in total

1.  Molecular orchestration of differentiation and function of regulatory T cells.

Authors:  Li-Fan Lu; Alexander Rudensky
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

2.  Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors.

Authors:  Julie L Lucas; Parham Mirshahpanah; Eric Haas-Stapleton; Khusru Asadullah; Thomas M Zollner; Robert P Numerof
Journal:  Cell Immunol       Date:  2009-04-08       Impact factor: 4.868

Review 3.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity.

Authors:  Kajsa Wing; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

4.  Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.

Authors:  Edwin F de Zoeten; Liqing Wang; Hong Sai; Wolfgang H Dillmann; Wayne W Hancock
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

5.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness.

Authors:  M G Guenther; W S Lane; W Fischle; E Verdin; M A Lazar; R Shiekhattar
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

6.  Epigenetic control of skull morphogenesis by histone deacetylase 8.

Authors:  Michael Haberland; Mayssa H Mokalled; Rusty L Montgomery; Eric N Olson
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

7.  Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.

Authors:  Hao Tang; Xiang S Wang; Xi-Ping Huang; Bryan L Roth; Kyle V Butler; Alan P Kozikowski; Mira Jung; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2009-02       Impact factor: 4.956

Review 8.  Regulatory T cells: how do they suppress immune responses?

Authors:  Shimon Sakaguchi; Kajsa Wing; Yasushi Onishi; Paz Prieto-Martin; Tomoyuki Yamaguchi
Journal:  Int Immunol       Date:  2009-09-07       Impact factor: 4.823

Review 9.  Human T regulatory cell therapy: take a billion or so and call me in the morning.

Authors:  James L Riley; Carl H June; Bruce R Blazar
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

Review 10.  Mechanisms of foxp3+ T regulatory cell-mediated suppression.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

View more
  54 in total

Review 1.  Histone/protein deacetylases and T-cell immune responses.

Authors:  Tatiana Akimova; Ulf H Beier; Yujie Liu; Liqing Wang; Wayne W Hancock
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

2.  Thiol-Based Potent and Selective HDAC6 Inhibitors Promote Tubulin Acetylation and T-Regulatory Cell Suppressive Function.

Authors:  Mariana C F Segretti; Gian Paolo Vallerini; Camille Brochier; Brett Langley; Liqing Wang; Wayne W Hancock; Alan P Kozikowski
Journal:  ACS Med Chem Lett       Date:  2015-10-05       Impact factor: 4.345

3.  The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.

Authors:  Michael J Kelly-Sell; Youn H Kim; Suzanne Straus; Bernice Benoit; Cameron Harrison; Katherine Sutherland; Randall Armstrong; Wen-Kai Weng; Louise C Showe; Maria Wysocka; Alain H Rook
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

4.  Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers.

Authors:  W M Chatila; G J Criner; W W Hancock; T Akimova; B Moldover; J-K Chang; W Cornwell; M Santerre; T J Rogers
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

5.  Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.

Authors:  Nicole L Regna; Cristen B Chafin; Sarah E Hammond; Abdul G Puthiyaveetil; David L Caudell; Christopher M Reilly
Journal:  Clin Immunol       Date:  2014-01-15       Impact factor: 3.969

6.  Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.

Authors:  Edwin F de Zoeten; Liqing Wang; Kyle Butler; Ulf H Beier; Tatiana Akimova; Hong Sai; James E Bradner; Ralph Mazitschek; Alan P Kozikowski; Patrick Matthias; Wayne W Hancock
Journal:  Mol Cell Biol       Date:  2011-03-28       Impact factor: 4.272

7.  Essential role of mitochondrial energy metabolism in Foxp3⁺ T-regulatory cell function and allograft survival.

Authors:  Ulf H Beier; Alessia Angelin; Tatiana Akimova; Liqing Wang; Yujie Liu; Haiyan Xiao; Maya A Koike; Saege A Hancock; Tricia R Bhatti; Rongxiang Han; Jing Jiao; Sigrid C Veasey; Carrie A Sims; Joseph A Baur; Douglas C Wallace; Wayne W Hancock
Journal:  FASEB J       Date:  2015-02-13       Impact factor: 5.191

8.  Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity.

Authors:  Kailin Yan; Qiang Cao; Christopher M Reilly; Nicolas L Young; Benjamin A Garcia; Nilamadhab Mishra
Journal:  J Biol Chem       Date:  2011-06-27       Impact factor: 5.157

Review 9.  Modulation of antitumor immunity with histone deacetylase inhibitors.

Authors:  Tyler R McCaw; Troy D Randall; Andres Forero; Donald J Buchsbaum
Journal:  Immunotherapy       Date:  2017-12       Impact factor: 4.196

Review 10.  Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.

Authors:  Manuela Terranova-Barberio; Scott Thomas; Pamela N Munster
Journal:  Immunotherapy       Date:  2016-06       Impact factor: 4.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.